Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 6(1):213. https://doi.org/10.2147/CLEP.S47385
Article PubMed PubMed Central Google Scholar
Miyasaka Y et al (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114(2):119–125. https://doi.org/10.1161/CIRCULATIONAHA.105.595140
Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988. https://doi.org/10.1161/01.STR.22.8.983
Article CAS PubMed Google Scholar
Fay MR, Fitzmaurice DA, Freedman B (2017) Screening of older patients for atrial fibrillation in general practice: current evidence and its implications for future practice. Eur J General Pract 23(1):246–253. https://doi.org/10.1080/13814788.2017.1374366 (Taylor and Francis Ltd)
Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69(19):1570–1573. https://doi.org/10.1016/0002-9149(92)90705-4
Article CAS PubMed Google Scholar
Wang TJ et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. Circulation 107(23):2920–2925. https://doi.org/10.1161/01.CIR.0000072767.89944.6E
Bunch TJ et al (2010) Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Hear Rhythm 7(4):433–437. https://doi.org/10.1016/J.HRTHM.2009.12.004
Freeman JV, Wang Y, Akar J, Desai N, Krumholz H (2017) National trends in atrial fibrillation hospitalization, readmission, and mortality for Medicare beneficiaries, 1999–2013. Circulation 135(13):1227–1239. https://doi.org/10.1161/CIRCULATIONAHA.116.022388
Lee E et al (2018) Mortality and causes of death in patients with atrial fibrillation: a nationwide population-based study. PLoS ONE. https://doi.org/10.1371/JOURNAL.PONE.0209687
Article PubMed PubMed Central Google Scholar
Flaker GC et al (2005) Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149(4):657–663. https://doi.org/10.1016/J.AHJ.2004.06.032
Gibbs H et al (2021) Clinical outcomes in asymptomatic and symptomatic atrial fibrillation presentations in GARFIELD-AF: implications for AF screening. Am J Med 134(7):893-901.e11. https://doi.org/10.1016/J.AMJMED.2021.01.017
Article CAS PubMed Google Scholar
Potpara TS, Polovina MM, Marinkovic JM, Lip GYH (2013) A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol 168(5):4744–4749. https://doi.org/10.1016/J.IJCARD.2013.07.234
Thind M et al (2018) Embolic and other adverse outcomes in symptomatic versus asymptomatic patients with atrial fibrillation (from the ORBIT-AF Registry). Am J Cardiol 122(10):1677–1683. https://doi.org/10.1016/J.AMJCARD.2018.07.045
Borowsky LH, Regan S, Chang Y, Ayres A, Greenberg SM, Singer DE (2017) First diagnosis of atrial fibrillation at the time of stroke. Cerebrovasc Dis 43(3–4):192–199. https://doi.org/10.1159/000457809
Sposato LA, Cipriano LE, Saposnik G, Vargas ER, Riccio PM, Hachinski V (2015) Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 14(4):377–387. https://doi.org/10.1016/S1474-4422(15)70027-X
Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med 98(5):476–484. https://doi.org/10.1016/S0002-9343(99)80348-9
Article CAS PubMed Google Scholar
Heeringa J et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27(8):949–953. https://doi.org/10.1093/EURHEARTJ/EHI825
Mandalenakis Z et al (2015) The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. EP Eur 17(7):1018–1022. https://doi.org/10.1093/EUROPACE/EUV036
Schnabel RB et al (2015) Fifty-year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the community. Lancet (London, England) 386(9989):154. https://doi.org/10.1016/S0140-6736(14)61774-8
Turakhia MP et al (2015) Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States. Am J Cardiol 116(5):733–739. https://doi.org/10.1016/j.amjcard.2015.05.045
Duarte R et al (2020) Journals Library Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. Health Technol Assess. https://doi.org/10.3310/hta24030
Article PubMed PubMed Central Google Scholar
Svennberg E et al (2017) Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation. Europace 19(9):1449–1453. https://doi.org/10.1093/europace/euw286
Uittenbogaart SB et al (2020) Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. BMJ 370:m3208. https://doi.org/10.1136/bmj.m3208
Article PubMed PubMed Central Google Scholar
Petryszyn P et al (2019) Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLoS ONE. https://doi.org/10.1371/JOURNAL.PONE.0213198
Article PubMed PubMed Central Google Scholar
Mairesse GH et al (2017) Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace 19(10):1589–1623. https://doi.org/10.1093/europace/eux177 (Oxford University Press)
Hutton B et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784. https://doi.org/10.7326/M14-2385
Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https://doi.org/10.1136/BMJ.L4898
Article PubMed PubMed Central Google Scholar
Benito L et al (2015) EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre. EP Eur 17(11):1688–1693. https://doi.org/10.1093/EUROPACE/EUV146
Fitzmaurice DA et al (2007) Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 335(7616):383. https://doi.org/10.1136/BMJ.39280.660567.55
Article PubMed PubMed Central Google Scholar
Gladstone DJ et al (2021) Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol 6(5):558–567. https://doi.org/10.1001/jamacardio.2021.0038
Halcox JPJ et al (2017) Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation the REHEARSE-AF study. Circulation 136(19):1784–1794. https://doi.org/10.1161/CIRCULATIONAHA.117.030583
Kaasenbrood F et al (2020) Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial. Br J Gen Pract 70(695):e427–e433. https://doi.org/10.3399/bjgp20X708161
Article PubMed PubMed Central Google Scholar
Mancinetti M, Schukraft S, Faucherre Y, Cook S, Arroyo D, Puricel S (2021) Handheld ECG tracking of in-hOspital Atrial Fibrillation (HECTO-AF): a randomized controlled trial. Front Cardiovasc Med 8:681890. https://doi.org/10.3389/FCVM.2021.681890
Article PubMed PubMed Central Google Scholar
Morgan S and Mant D (2002) Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract 52(478)
Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M (2021) Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. https://doi.org/10.1016/S0140-6736(21)01637-8
Wilson J, Jungner G (1968) Principles and practice of screening for disease. Wold Health Organization, Switzerland, p 34 (Public Health Pap., 1968)
World Health Organization. Regional Office for Europe (2020) Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. World Health Organization. Regional Office for Europe. https://apps.who.int/iris/handle/10665/330829
Speechley M, Kunnilathu A, Aluckal E, Balakrishna MS, Mathew B, George EK (2017) Screening in Public health and clinical care: similarities and differences in definitions, types, and aims—a systematic review. J Clin Diagn Res 11(3):LE01. https://doi.org/10.7860/JCDR/2017/24811.9419
Article PubMed PubMed Central Google Scholar
Burdett P, Lip GYH (2022) Targeted vs full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom. Eur Hear J. https://doi.org/10.1093/EHJQCCO/QCAC005
Hindricks G et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa612
留言 (0)